Gaps in Gastric Cancer Risk Factor Management: Analysis of Electronic Health Data and Provider/Patient Perspectives
Abstract
This study addressed factors and their interactions contributing to disparities in testing and treatment of H. pylori (HP) infection and related gastric disorders (atrophic gastritis, gastric ulcer), and gastric cancer [GC; gastric adenocarcinoma (GCA), gastric non-Hodgkins lymphoma (GL) and gastric MALT lymphoma (gMALT) diagnosis and treatment, among Latinos relative to non-Latinos at two affiliated but independent health systems in San Antonio, Texas. Secondary data collection/analysis of electronic health records (EHR) showed the study cohort was predominantly female, Hispanic, H. pylori positive (for non-GC disorders), seen via ambulatory visit at the safety-net hospital system (UHS), and insured by local safety net (Carelink) or other subsidized plans (Medicare, Medicaid, SCHIP). There was an increasing trend in all GCs over the period studied 2007-2018. Updated dataset (05/2020) included ages 18-88 and all races, with cohort characteristics essentially unchanged. Most commonly prescribed antibiotic regimen was Clarithromycin triple therapy followed by Bismuth quadruple therapy.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2020
- Accession Number
- AD1110076
Entities
People
- Ariel B. Morales
- Dorothy L. Parma
Organizations
- University of Texas Health Science Center at San Antonio